All In Biotech

Free tool

FAERS Monitor: Dextenza

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208742 or its brand name (Dextenza, Dexamethasone). Reports on generic versions are filed under their own applications.

Reports

295,403

Serious

250,069

85% of reports

Hospitalization

114,035

Death reported

48,053

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use22,661
  • fatigue17,491
  • diarrhoea17,299
  • plasma cell myeloma14,401
  • nausea14,166
  • pneumonia13,815
  • death13,363
  • drug ineffective13,179
  • neutropenia11,779
  • pyrexia11,104
  • thrombocytopenia10,770
  • dyspnoea10,382
  • febrile neutropenia9,199
  • anaemia9,123
  • vomiting8,877

Reports by year received

View as table
YearReports
20041,561
20052,135
20061,096
2007875
20081,308
20091,923
20103,580
20115,377
20126,679
20136,720
20148,343
201517,378
201615,820
201717,840
201823,304
201923,260
202025,188
202128,943
202227,273
202324,148
202421,459
202518,425
202612,766

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,758,756 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
plasma cell myelomaSignal14,40141.040.2355,834
febrile neutropeniaSignal9,19911.311.174,634
thrombocytopeniaSignal10,7707.57.354,938
neutropeniaSignal11,7796.76.552,064
anaemiaSignal9,1233.53.515,866
pneumoniaSignal13,8153.13.119,455
pyrexiaSignal11,1042.32.38,272
diarrhoea17,2991.91.97,822
off label use22,6611.91.89,240
fatigue17,4911.61.64,140
vomiting8,8771.41.3812
dyspnoea10,3821.31.3775
nausea14,1661.31.3882
death13,3631.11.1139
drug ineffective13,1790.70.71,661

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.